Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

After The Supply Pact, Will GSK Go For An Equity Deal With Dr. Reddy's?

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - Weeks after the Paris-headquartered Sanofi-Aventis acquired Hyderabad-based Shantha Biotechnics to galvanize the French drug maker's preventative vaccines manufacturing, analysts are now predicting a deal between Britain's GlaxoSmithKline and Dr. Reddy's - India's second biggest pharmaceutical company as measured by sales

You may also be interested in...



M&A In India May Lose Steam As Potential Sellers Raise Prices, Investment Bankers Say

A rebound in the Indian stock market and two recent high-value takeovers sparked "irrational hope" in overvalued mid-size companies.

M&A In India May Lose Steam As Potential Sellers Raise Prices, Investment Bankers Say

A rebound in the Indian stock market and two recent high-value takeovers sparked "irrational hope" in overvalued mid-size companies.

M&A In India May Lose Steam As Potential Sellers Raise Their Price Tags, Investment Bankers Say

MUMBAI - Greed is getting in the way of several prospective mergers and acquisitions in the Indian pharmaceutical industry, two senior investment bankers told PharmAsia News, but reiterated that multinational companies are still keenly scanning companies that fit into their global programs

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

SC072740

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel